The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Originally identified in Drosophila melanogaster, the Warts(Wts)/Lats protein kinase has been proposed to function with two other Drosophila proteins, Hippo (Hpo) and Salvador (Sav), in the regulation of cell cycle exit and apoptosis. In mammals, two candidate Warts/Lats homologs, termed Lats1 and Lats2, have been described, and the targeted disruption of LATS1 in mice increases tumor formation. Little, however, is known about the function and regulation of human Lats kinases. Here we report that human Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2. Deletion analysis revealed that regulation of Lats1 occurs through the C-terminal, catalytic domain. Within this domain, two regulatory phosphorylation sites were identified by mass spectrometry. These sites, S909 in the activation loop and T1079 within a hydrophobic motif, have been highly conserved during evolution. Moreover, a direct interaction was observed between Mst2 and hWW45, a putative ortholog of Drosophila Sav. These results indicate that Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway. Although the function of this pathway remains poorly understood in mammals, it is intriguing that, in Drosophila, it has been linked to development and tissue homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, LATS1 requires phosphorylation to be active [105] and LATS1 phosphorylation was increased on the non-acetylated, less stable LATS1K751R [104].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [105]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P., Halladay, J., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,637
Active and Inactive Protein Kinases: Structural Basis for Regulation
Johnson, L. N., Noble, M. E. M., & Owen, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81092-2 · Cited by 1,403 · cited 2×
“Interestingly, these sites are located within the activation loop (S909) and a hydrophobic motif (T1079), two domains previously been implicated in the activation of other kinases (Johnson et al., 1996; Tamaskovic et al., 2003).”
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098 · cited 10×
“When expressed in Drosophila, Mst2 was able to rescue the hpomutant phenotype, showing that it can act as a functional ortholog (Wu et al., 2003).”
BackgroundResultInfluentialDammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976 · cited 7×
“These data suggested that Wts/Lats, Sav and Hpo might form a trimeric complex in which Sav functions as an adaptor protein to bring Wts/Lats in close proximity to Hpo (Harvey et al., 2003).”
BackgroundResultInfluentialTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 7×
“…neither the N-terminally located putative UBA domain, a structure believed to bind ubiquitin moieties (Buchberger, 2002), nor the PPXY motifs, previously implicated in mediating the interaction between Wts/lats and Sav in Drosophila (Tapon et al., 2002), were required for this regulation.”
BackgroundResultInfluentialXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Cited by
Items 201–300 of 604
Regulation of the Hippo signaling pathway by ubiquitin modification
Kim, Y., & Jho, E. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.017 · Cited by 66
“MST1/2 increases the binding affinity to LATS1/2, which in turn leads to auto-phosphorylation of LATS1/2 on Ser909/872 and increases their kinase activity for full activation (51-53).”
BackgroundVrabioiu, A. M., & Struhl, G. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.11.027 · Cited by 62
“Dachs Is Independent of Wts Phosphorylation by Hpo Hpo family kinases phosphorylate NDR kinases at a conserved threonine residue, T1083 (http://flybase.org/), within the hydrophobic motif of Wts (Chan et al., 2005).”
InfluentialElaimy, A. L., Guru, S. K., Chang, C., Ou, J., Amante, J. J., Zhu, L. J., Goel, H. L., & Mercurio, A. M. (2018) · Science Signaling · doi:10.1126/scisignal.aao6897 · Cited by 65
KIBRA Protein Phosphorylation Is Regulated by Mitotic Kinase Aurora and Protein Phosphatase 1
Xiao, L., Chen, Y., Ji, M. H., Volle, D. J., Lewis, R. E., Tsai, M.-Y., & Dong, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246850 · Cited by 65
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Schagdarsurengin, U., Richter, A. M., Hornung, J., Lange, C., Steinmann, K., & Dammann, R. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-264 · Cited by 68
“MST and WW45 or RASSF1A and RASSF5 interaction [ 22-24 ].”
BackgroundYAP/TAZ in Bone and Cartilage Biology
Zarka, M., Haÿ, E., & Cohen-Solal, M. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.788773 · Cited by 70
Morgan, J. T., Murphy, C. J., & Russell, P. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.06.012 · Cited by 57
“The concept of Hippo being linked to the actin cytoskeleton at or above Lats is supported by the recent research in Drosophila, where studies indicated increasing or decreasing filamentous actin resulting in increased or decreased Yki activity, respectively, and this involved the Lats homolog, Wts (Rauskolb et al., 20…”
InfluentialRegulators of mammalian Hippo pathway in cancer
Liu, A. M., Wong, K., Jiang, X., Qiao, Y., & Luk, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.006 · Cited by 68
Hirabayashi, S., Nakagawa, K., Sumita, K., Hidaka, S., Kawai, T., Ikeda, M., Kawata, A., Ohno, K., & Hata, Y. (2008) · Oncogene · doi:10.1038/onc.2008.66 · Cited by 66
A conserved MST1/2–YAP axis mediates Hippo signaling during lung growth
Lin, C., Yao, E., & Chuang, P.-T. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.04.014 · Cited by 57
“In mammals, the STE20-like protein kinases, MST1/2, phosphorylate and activate the large tumor suppressor kinases, LATS1/2 (Chan et al., 2005).”
Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury
Nakamura, M., Zhai, P., Re, D. P. D., Maejima, Y., & Sadoshima, J. (2016) · JCI Insight · doi:10.1172/jci.insight.86217 · Cited by 60
LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression
Chiyoda, T., Sugiyama, N., Shimizu, T., Naoe, H., Kobayashi, Y., Ishizawa, J., Arima, Y., Tsuda, H., Ito, M., Kaibuchi, K., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201110110 · Cited by 60
“293T cells were transfected with a HA-tagged wild-type or kinase-dead (KD) mutant of LATS1 and subsequently treated with okadaic acid to activate the exogenous kinase (Chan et al., 2005).”
O -GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
Kim, E., Kang, J. G., Kang, M. J., Park, J. H., Kim, Y. J., Kweon, T. H., Lee, H., Jho, E., Lee, Y., Kim, S.-I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913469117 · Cited by 58
“LATS2 requires additional phosphorylation at Ser872 located in the activation loop to be fully activated (14, 16).”
BackgroundHo, L., Wei, X., Shimizu, T., & Lai, Z.-C. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.10.042 · Cited by 62
The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy
Wang, H., Du, Y. C., Zhou, X. J., Liu, H., & Tang, S. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9463-3 · Cited by 62
Hippo signalling in intestinal regeneration and cancer
Gregorieff, A., & Wrana, J. L. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.04.005 · Cited by 61
Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance
Tsoi, M. F., Morin, M., Rico, C., Johnson, R. L., Paquet, M., Gévry, N. Y., & Boerboom, D. (2019) · The FASEB Journal · doi:10.1096/fj.201900609r · Cited by 60
LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity
Pisarska, M. D., Kuo, F., Bentsi-Barnes, I. K., Khan, S., & Barlow, G. M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00534.2009 · Cited by 65
“1His-Xpress-LATS1 expression construct, 100 ng of the kinaseinactive D846A mutant LATS1 expression construct, or 100 ng of the empty pcDNA3.”
MethodInfluentialNogueira, E., Fidalgo, M., Molnar, A., Kyriakis, J. M., Force, T. L., Zalvide, J. B., & Pombo, C. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709724200 · Cited by 63
Brace, J., Hsu, J., & Weiss, E. L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00403-10 · Cited by 55
“2-fold serial dilutions of MBP-Cbk1(1-333), starting with 0.”
BackgroundMethodInfluentialHippo pathway and protection of genome stability in response to DNA damage
Pefani, D. E., & O'Neill, E. (2016) · The FEBS Journal · doi:10.1111/febs.13604 · Cited by 56
Jagannathan, R., Schimizzi, G. V., Zhang, K., Loza, A. J., Yabuta, N., Nojima, H., & Longmore, G. D. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00136-16 · Cited by 63
“LATS1/LATS2 in turn phosphorylate the transcriptional coactivators YAP and TAZ (Drosophila Yki) at multiple sites, some of which lead to the sequestration of YAP/TAZ in the cytosol through an interaction with 14-3-3 proteins, while others target YAP/TAZ for degradation by the proteasome (4, 6).”
BackgroundKpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
Kawahara, M., Hori, T., Chonabayashi, K., Oka, T., Sudol, M., & Uchiyama, T. (2008) · Blood · doi:10.1182/blood-2007-09-111773 · Cited by 65
Endosomal phosphatidylserine is critical for the YAP signalling pathway in proliferating cells
Matsudaira, T., Mukai, K., Noguchi, T., Hasegawa, J., Hatta, T., Iemura, S.-I., Natsume, T., Miyamura, N., Nishina, H., Nakayama, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01255-3 · Cited by 57
MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis
Kim, J.-Y., Kwon, H., Shin, Y. K., Song, G., Lee, T. B., Kim, Y., Jeong, W., Lee, U., Zhang, X., Nam, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917969117 · Cited by 60
“Activation of the Hippo pathway is triggered by a core kinase cassette that comprises the mammalian sterile 20-like kinases (MST1/ 2), the large tumor suppressor (LATS1/2), and the scaffold protein Salvador1 (SAV1) (16).”
BackgroundZhou, X., & Lei, Q. (2016) · Protein & Cell · doi:10.1007/s13238-016-0288-z · Cited by 57
“LATS1/2 are fully activated by MOB1 and then phosphorylate the downstream targets, i.e., YAP and TAZ (Bothos et al., 2005; Chan et al., 2005; Harvey & Tapon, 2007; Hergovich, 2011; Hergovich et al., 2006; Hoa et al., 2016; Zhao et al., 2010a).”
BackgroundMOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway
Couzens, A. L., Xiong, S., Knight, J. D. R., Mao, D. Y. L., Guettler, S., Picaud, S., Kurinov, I. V., Filippakopoulos, P., Sicheri, F., & Gingras, A. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.065490 · Cited by 59
“The canonical mammalian Hippo pathway consists of a short kinase cascade in which mammalian STE20-like protein kinase 1 and 2 (MST1 and MST2 kinases) 1 (gene names STK4 and STK3; Hpo in flies) phosphorylate and activate the down-stream kinases LATS1 and LATS2 (Warts in flies 6, 13).”
Jiménez, A. P., Traum, A., Boettger, T., Hackstein, H., Richter, A. M., & Dammann, R. (2017) · Oncotarget · doi:10.18632/oncotarget.18177 · Cited by 58
“The methylation of ANKRD1, RASSF1A, MST1, MST2, WW45, LATS1, LATS2, YAP1 and KIBRA promoters were analyzed via combined bisulfite restriction analysis (CoBRA) as described previously [34, 60].”
InfluentialZhang, Q., Han, X., Chen, J., Xie, X., Xu, J., Zhao, Y., Shen, J., Hu, L. T., Xu, P., Song, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004251 · Cited by 65
“Once the Hippo kinase module is activated, the upstream kinases MST1/2 are activated, which in turn phosphorylate and activate LATS1/2 (23, 24).”
BackgroundYAP in pancreatic cancer: oncogenic role and therapeutic strategy
Mao, W., Mai, J., Peng, H., Wan, J., & Sun, T. (2020) · Theranostics · doi:10.7150/thno.53438 · Cited by 60
“Phosphorylated LATS1/2 enhances autophosphorylation at their activation loop and phosphorylated MOB1 binds to the autoinhibitory domain of LATS1/2, leading to full activation [22, 24].”
BackgroundMammalian Sterile 20–Like Kinases in Tumor Suppression: An Emerging Pathway
O’Neill, E. E., Matallanas, D., & Kölch, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1453 · Cited by 54
“Recently, biochemical evidence has been provided for the activation of human Lats1 by MST2 (16).”
BackgroundDaxx mediates activation‐induced cell death in microglia by triggering MST1 signalling
Yun, H. J., Yoon, J., Lee, J. K., Noh, K. T., Yoon, K.-W., Oh, S. P., Oh, H. J., Chae, J. S., Hwang, S. G., Kim, E. H., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.152 · Cited by 55
MST1 Limits the Kinase Activity of Aurora B to Promote Stable Kinetochore-Microtubule Attachment
Oh, H. J., Kim, M. J., Song, S. J., Kim, T., Lee, D., Kwon, S., Choi, E., & Lim, D. (2010) · Current Biology · doi:10.1016/j.cub.2009.12.054 · Cited by 54
Targeting the Hippo pathway in heart repair
Meng, F., Xie, B., & Martin, J. F. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab291 · Cited by 56
Role of Hippo Signaling in Cancer Stem Cells
Hao, J., Zhang, Y., Jing, D., Li, Y., Li, J., & Zhao, Z. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24455 · Cited by 55
“The Lats1/2 promoters are hypermethylated in almost 50% of breast cancers and 60–70% of astrocytomas (Takahashi et al., 2005; Jiang et al., 2006).”
BackgroundInfluentialAtypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling
Archibald, A., Al‐Masri, M., Liew-Spilger, A., & McCaffrey, L. M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-05-0265 · Cited by 55
“This was unexpected because it was reported that phosphorylation of Lats1/2 on Ser-909 was dependent on Mst1/2 activity (Chan et al., 2005).”
BackgroundApoptosis Signaling Kinases: From Stress Response to Health Outcomes
Takeda, K., Naguro, I., Nishitoh, H., Matsuzawa, A., & Ichijo, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3392 · Cited by 56
“Concerning the regulation of LATS1 and LATS2, MST2 has been proposed to phosphorylate these substrates more effectively than MST1 (34).”
Grieve, S., Hao, Y., & Yang, X. (2011) · Oncogene · doi:10.1038/onc.2011.318 · Cited by 53
Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
Watt, K. I., Harvey, K. F., & Gregorevic, P. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00942 · Cited by 57
“Phosphorylated LATS1/2 and/or NDR1/2 then undergo auto-phosphorylation in an activation loop (Chan et al., 2005).”
BackgroundO-GlcNAcylation regulation of cellular signaling in cancer
Ciraku, L., Esquea, E. M., & Reginato, M. J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110201 · Cited by 52
The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4
Ahn, Y., Hwang, C. Y., Lee, S.-R., Kwon, K., & Lee, C. (2008) · Biochemical Journal · doi:10.1042/bj20071403 · Cited by 55
Fujimoto, D., Ueda, Y., Hirono, Y., Goi, T., & Yamaguchi, A. (2015) · Oncotarget · doi:10.18632/oncotarget.5858 · Cited by 50
“Lats1/2 forms a cascade to increase YAP phosphorylation [26].”
BackgroundRole Of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer
Zhou, W., Lim, A., Edderkaoui, M., Osipov, A., Wu, H., Wang, Q., & Pandol, S. J. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83586 · Cited by 52
“The kinase activity of MST1/2 can be activated by binding to the Salvador Family WW Domain Containing Protein 1 (SAV1), a scaffold protein that also forms a complex with LATS1/2[11, 28, 29, 34].”
BackgroundMiller, C. J., Lou, H. J., Simpson, C. D., van de Kooij, B., Ha, B. H., Fisher, O. S., Pirman, N. L., Boggon, T. J., Rinehart, J., Yaffe, M. B., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2006540 · Cited by 54
Developmental Pathways Hijacked by Osteosarcoma
Mortus, J., Zhang, Y., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_5 · Cited by 49
Yee, K. S. Y., Grochola, L. F., Hamilton, G., Grawenda, A. M., Bond, E. E., Taubert, H. W., Würl, P., Bond, G. L., & O’Neill, E. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2906 · Cited by 55
“It has previously been shown that MST2 phosphorylates LATS1 on 2 critical residues, Ser909 and Thr1079, resulting in LATS1 kinase activation (36).”
BackgroundMolina, E. R., Chim, L. K., Salazar, M. C., Mehta, S. M., Menegaz, B. A., Lamhamedi-Cherradi, S.-E., Satish, T., Mohiuddin, S., McCall, D. C., Zaske, A. M., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.029 · Cited by 49
The GCK II and III subfamilies of the STE20 group kinases
Pombo, C. M., Force, T., Kyriakis, J., Nogueira, E., Fidalgo, M., & Zalvide, J. (2006) · Frontiers in bioscience · doi:10.2741/2107 · Cited by 53
“It also seems apparent that the pathway has been evolutionary conserved since Mst2 and hWW45 interact with each other in human cells, and both Mst1 and Mst2 are able to phosphorylate Lats-1 and Lats-2, thereby stimulating Lats kinase activity (40).”
BackgroundGógl, G., Schneider, K. D., Yeh, B. J., Nashida, A., Ba, A. N. N., Moses, A. M., Hetényi, C., Reményi, A., & Weiss, E. L. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002146 · Cited by 51
Astone, M., Lai, J. K. H., Dupont, S., Stainier, D. Y. R., Argenton, F., & Vettori, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-27657-x · Cited by 49
Lamin Mutations Cause Increased YAP Nuclear Entry in Muscle Stem Cells
Owens, D. J., Fischer, M., Jabre, S., Moog, S., Mamchaoui, K., Butler-Browne, G., & Coirault, C. (2020) · Cells · doi:10.3390/cells9040816 · Cited by 44
Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis
Emami, S. S., Zhang, D., & Yang, X. (2020) · Cancers · doi:10.3390/cancers12092438 · Cited by 49
Ray, S., Kume, K., Gupta, S. V., Ge, W., Balasubramanian, M. K., Hirata, D., & McCollum, D. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201002055 · Cited by 47
A global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1)
Priyanka, P., Gopalakrishnan, A. P., Nisar, M., Shivamurthy, P. B., George, M., John, L., Sanjeev, D., Yandigeri, T., Thomas, S. D., Rafi, A., et al. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106558 · Cited by 50
Valencia-Sama, I., Zhao, Y., Lai, D., van Rensburg, H. J. J., Hao, Y., & Yang, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642363 · Cited by 52
N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability
Yabuta, N., Mukai, S., Okamoto, A., Okuzaki, D., Suzuki, H., Torigata, K., Yoshida, K., Okada, N., Miura, D., Ito, A., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.113431 · Cited by 44
Meliambro, K. A., Wong, J., Ray, J., Calizo, R. C., Towne, S. B., Cole, B., Salem, F. E., Gordon, R. E., Kaufman, L., He, C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.819029 · Cited by 47
“Given that the phosphorylated form of LATS kinase is active whereas the phosphorylated form of YAP is inactive (29, 32), these results suggest that KIBRA/Wwc1 overexpression can induce LATS-mediated YAP inactivation in murine podocytes.”
BackgroundHein, A. L., Brandquist, N. D., Ouellette, C. Y., Seshacharyulu, P., Enke, C. A., Ouellette, M. M., Batra, S. K., & Yan, Y. (2019) · Oncogenesis · doi:10.1038/s41389-019-0172-9 · Cited by 53
Fan, S., Price, T. T., Huang, W., Plue, M., Warren, J. L., Sundaramoorthy, P., Paul, B. A., Feinberg, D. M., MacIver, N. J., Chao, N. J. A., et al. (2020) · Advanced Science · doi:10.1002/advs.201900860 · Cited by 51
Salvador Protein Is a Tumor Suppressor Effector of RASSF1A with Hippo Pathway-independent Functions
Donninger, H., Allen, N. P. C., Henson, A. L., Pogue, J., Williams, A., Gordon, L. E., Kassler, S., Dunwell, T. L., Latif, F., & Clark, G. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214874 · Cited by 50
Amot and Yap1 regulate neuronal dendritic tree complexity and locomotor coordination in mice
Rojek, K. O., Krzemień, J., Doleżyczek, H., Boguszewski, P. M., Kaczmarek, L., Konopka, W., Rylski, M., Jaworski, J., Holmgren, L., & Prószyński, T. J. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000253 · Cited by 48
The integration of signaling by multiprotein complexes containing Raf kinases
Kyriakis, J. M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.003 · Cited by 48
The growing role of the Hippo-NDR kinase signalling in neuronal development and disease
Emoto, K. (2011) · Journal of Biochemistry · doi:10.1093/jb/mvr080 · Cited by 44
GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer
Yagi, H., Asanoma, K., Ohgami, T., Ichinoe, A., Sonoda, K., & Kato, K. (2016) · Oncogene · doi:10.1038/onc.2015.505 · Cited by 46
Uemura, M., Nagasawa, A., & Terai, K. (2016) · Scientific Reports · doi:10.1038/srep27473 · Cited by 43
The transcriptional co-activator YAP: A new player in head and neck cancer
Segrelles, C., Paramio, J. M., & Lorz, C. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.08.020 · Cited by 43
STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism
Bae, S. J., Ni, L., & Luo, X. (2020) · eLife · doi:10.7554/elife.54863 · Cited by 45
“When the Hippo pathway is on, the MST1/2–SAV1 complexes phosphorylate and activate the LATS1/2–MOB1 complexes (Chan et al., 2005; Praskova et al., 2008).”
BackgroundLyu, Z., Qin, N., Tyasi, T. L., Zhu, H., Liu, D., Yuan, S., & Xu, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160896 · Cited by 44
“Previous studies have demonstrated that SAV1 recruits LATS to the MST to promote the phosphorylation of LATS mediated by MST1 (homologue of Ser/Thr kinase 4, STK4 in chicken) and MST2 (STK3 in chicken) [30, 31], and that SAV1 is required for the correct cellular localization and function of MST [32].”
BackgroundEmerging roles of Hippo signaling in inflammation and YAP-driven tumor immunity
Zhou, Y., Huang, T., Zhang, J., Cheng, A. S. L., Yu, J. Q., Kang, W., & To, K. F. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.004 · Cited by 42
Merlin Is a Negative Regulator of Human Melanoma Growth
Murray, L. B., Lau, Y.-K. I., & Yu, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043295 · Cited by 44
The Role of the Hippo Pathway in Melanocytes and Melanoma
Kim, J. E., Finlay, G. J., & Baguley, B. C. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00123 · Cited by 42
“Expanded also directly associates with Yorkie in Drosophila to inhibit growth of the Hippo pathway by sequestering Yorkie in the cytoplasm (Badouel et al., 2009).”
BackgroundInfluentialRegulation of Protein Interactions by Mps One Binder (MOB1) Phosphorylation
Xiong, S., Couzens, A. L., Kean, M. J., Mao, D. Y. L., Guettler, S., Kurinov, I. V., Gingras, A., & Sicheri, F. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.068130 · Cited by 41
Role of YAP in lung cancer resistance to cisplatin
Song, J., Xie, L., Zhang, X., Hu, P., Long, M., Xiong, F., Huang, J., & Ye, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9141 · Cited by 41
“YAP carries out its function by translocating into nuclear and inducing the transcription of genes involved in proliferation and anti-apoptosis (14,15), whereas the activation of Hippo pathway limits YAP function by inducing YAP phosphorylation and impairing its nuclear translocation (16,17).”
Context-dependent transcriptional regulations of YAP/TAZ in cancer
Guo, Y., Luo, J., Zou, H., Liu, C., Deng, L., & Li, P. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.019 · Cited by 41
Lou, J., Lu, Y., Cheng, J., Zhou, F., Yan, Z., Zhang, D., Meng, X., & Zhao, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114684 · Cited by 40
RASSF1A-Mediated Regulation of AREG via the Hippo Pathway in Hepatocellular Carcinoma
Ahn, E. Y., Kim, J. S., Kim, G. J., & Park, Y. N. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0665 · Cited by 43
“Our results revealed that RASSF1A induced phosphorylation of MST, which reportedly activates the Hippo pathway (29, 30).”
BackgroundRoles and functions of IAV proteins in host immune evasion
Rashid, F., Xie, Z., Li, M., Xie, Z., Luo, S., & Xie, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323560 · Cited by 40
Clinical implications of the Hippo-YAP pathway in multiple cancer contexts
Kim, H., & Myung, S. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.018 · Cited by 39
Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma
Molina, E. R., Chim, L. K., Barrios, S., Ludwig, J. A., & Mikos, A. G. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0302 · Cited by 40
“First, the FAK complex, through a series of events, activates Akt through the canonical IGF-1R/mTOR pathway by promoting the activity of PI3K.76,77 Akt then inhibits MST1/2 leading to a downregulation of the core Hippo pathway and subsequently increased nuclear YAP.78 Second, a substrate stiffness signal cascade depen…”
BackgroundClinical significance of the loss of MATS1 mRNA expression in colorectal cancer
Kosaka, Y., Mimori, K., Tanaka, F., Inoue, H., Watanabe, M., & Mori, M. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.2.333 · Cited by 42
Flow signaling and atherosclerosis
Le, N., Sandhu, U. G., Quintana-Quezada, R. A., Hoang, N. M., Fujiwara, K., & Abe, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2442-4 · Cited by 40
“form active enzymes and phosphorylate and activate LATSs [92].”
InfluentialThe Effects of YAP and Its Related Mechanisms in Central Nervous System Diseases
Jin, J., Zhao, X., Fu, H., & Gao, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00595 · Cited by 41
“, 2010a), including mammalian STE20-like protein kinase 1/2 (Mst1/2), Salvador family WW domaincontaining protein 1 (SAV1), large tumor suppressor substance 1/2 (LATs1/2), MOB kinase activator (MOB1), Yes-associated protein (YAP) and its paralog, and TAZ and TEA domaincontaining sequence-specific transcription factors…”
BackgroundBata, N., Chaikuad, A., Bakas, N. A., Limpert, A. S., Lambert, L. J., Sheffler, D. J., Berger, L. M., Liu, G., Yuan, C., Wang, L., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00804 · Cited by 38
Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels
Bai, X., Huang, L., Niu, L., Zhang, Y., Wang, J., Sun, X., Jiang, H., Zhang, Z., Miller, H. E., Tao, W., et al. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000588 · Cited by 37
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
Zhang, S., Wang, J., Wang, H., Fan, L., Fan, B., Zeng, B., Tao, J., Li, X., Che, L., Cigliano, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.12.017 · Cited by 37
Mammalian Sterile20-like Kinases: Signalings and Roles in Central Nervous System
Chen, S., Fang, Y., Xu, S., Reis, C., & Zhang, J. (2018) · Aging and Disease · doi:10.14336/ad.2017.0702 · Cited by 37
“With the assistance of cofactor WW-domain scaffolding protein WW45 (Sav in Drosophila), MST1/2 binds and phosphorylates the downstream Nuclear Dbf2-related (NDR) family kinases and Large tumor suppressor (Lats1/2, as Warts in Drosophila), through interaction with SARAH domains [28].”
BackgroundFoxO6 regulates Hippo signaling and growth of the craniofacial complex
Sun, Z. Q., da Fontoura, C. S. G., Moreno, M., Holton, N. E., Sweat, M., Sweat, Y. Y., Lee, M. K., Arbon, J., Bidlack, F. B., Thedens, D. R., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007675 · Cited by 35
Wei, X., Huang, G., Liu, J., Ge, J., Zhang, W., & Mei, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114619 · Cited by 37
Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation
Zhang, P., Wang, S., Wang, S., Qiao, J., Zhang, L., Zhang, Z., & Chen, Z. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.21 · Cited by 38
Influenza A virus NS1 protein hijacks YAP/TAZ to suppress TLR3-mediated innate immune response
Zhang, Q., Zhang, X., Lei, X., Wang, H., Jiang, J., Wang, Y., Bi, K., & Diao, H. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010505 · Cited by 34
“Phosphorylated YAP/TAZ are sequestered in the cytoplasm by 14-3-3 proteins, which inhibit their transcriptional activity and leads to polyubiquitination and degradation of YAP/TAZ in the proteasome [27,28].”
BackgroundPeng, L., Zhou, L., Li, H., Zhang, X., Su, L., Wang, K., Yang, M., Ma, X., Zhang, D., Xiang, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114003 · Cited by 37
Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology
Chen, X., Ji, X., Lao, Z., Pan, B., Qian, Y., & Yang, W. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.12.003 · Cited by 50
Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway
Kim, S., Tachioka, Y., Mori, T., & Hakoshima, T. (2016) · Scientific Reports · doi:10.1038/srep28488 · Cited by 36
“1a) 7–9,31 and is essential for Here we report the results of structural and biochemical studies of full-length mouse MOB1B in the auto-inhibited form and that of the MOB core domain bound to the NTR region of LATS1 (hereafter referred to as the MOB1B-LATS1 complex).”
YAP and WWTR1: New targets for skin cancer treatment
Andl, T., Zhou, L., YANG, K. Y., Kadekaro, A. L., & Zhang, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.001 · Cited by 35
Kumari, G., Singhal, P. K., Rao, M. R. K. S., & Mahalingam, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.01.026 · Cited by 36
The regulation and function of the Hippo pathway in heart regeneration
Liu, S., & Martin, J. F. (2018) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.335 · Cited by 37
“In mice, kinases MST1/2 (orthologous to HPO) and their regulatory protein Salv1 (also known as WW45) form an activated complex (Callus, Verhagen, & Vaux, 2006; de Souza & Lindsay, 2004; Graves et al., 1998), which in turn directly phosphorylates the large tumor suppressor homolog kinases (LATS) 1/2 and their regulator…”
BackgroundInfluentialZhou, L., Wang, Q., Zhang, H., Li, Y., Xie, S., & Xu, M. (2019) · Biomolecules · doi:10.3390/biom9100620 · Cited by 36
“As shown in Figure 3b, nuciferine treatment markedly increased YAP Ser 127 phosphorylation, while phosphorylation of Ser 909 and Thr 1079 in LATS1 which is positively correlates with LATS activity [29,30] has no noticeable change.”
BackgroundVerteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells
Zhou, W. J., Lim, A., Elmadbouh, O. H. M., Edderkaoui, M., Osipov, A., Mathison, A., Urrutia, R. A., Liu, T., Wang, Q., & Pandol, S. J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.003 · Cited by 35
Croft, A. S., Roth, Y., Oswald, K. A. C., Ćorluka, S., Bermudez‐Lekerika, P., & Gantenbein, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413641 · Cited by 37
“Once the pathway is activated, mammalian STE20-like protein kinases 1 and 2 (MST1/2) autophosphorylate, form heterodimers with the Salvador family WW-domain-containing protein 1 (SAV1) and subsequently phosphorylate large tumor suppressor kinases 1 and 2 (LATS1/2) [21,22].”
BackgroundHTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis
Zhao, T., Wang, Z., Fang, J., Cheng, W., Zhang, Y., Huang, J., Xu, L., Gou, H., Zeng, L., Jin, Z., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115316119 · Cited by 39
Metadata
- Authors
- Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Silljé, Herman H W
- Venue
- Oncogene
- Published
- 2005-01-31
- Volume
- 24
- Issue
- 12
- Pages
- 2076-2086
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2105193974
- Cited by
- 584
- References
- 42
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 41 · 2023: 19 · 2022: 37 · 2021: 39 · 2020: 40 · 2019: 36 · 2018: 39 · 2017: 26 · 2016: 36 · 2015: 35 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Croucher Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- MST2, LATS1, LATS2, Ste20-like kinase, Hippo signaling pathway, Warts kinase, kinase activation, phosphorylation sites, catalytic domain, tumor suppressor kinase, cell cycle regulation, apoptosis
- MeSH terms
- Serine-Threonine Kinase 3, Hippo Kinases, Amino Acid Sequence, Animals, Cell Line, Drosophila melanogaster, Gene Expression Regulation, HeLa Cells, Humans, Kidney, Peptide Fragments, Genes, Tumor Suppressor, Protein Serine-Threonine Kinases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.